High-throughput fingerprinting of human pluripotent stem cell fate responses and lineage bias

Nature Methods

Volumn 10, Issue 12, 2013, Pages 1225-1231

  Nazareth, Emanuel J P ^a   Ostblom, Joel E E ^a,b   Lücker, Petra B ^a,c   Shukla, Shreya ^a   Alvarez, Manuel M ^a   Oh, Steve K W ^d   Yin, Ting ^a   Zandstra, Peter W ^a,c,e,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF TORONTO   (Canada)

^d AGENCY FOR SCIENCE   (Singapore)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f HEART AND STROKE FOUNDATION OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL LINE; DNA FINGERPRINTING; DOSE RESPONSE; ENDODERM; HUMAN; MICROENVIRONMENT; NEUROECTODERM; NONHUMAN; PLURIPOTENT STEM CELL; PRIMITIVE STREAK; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CULTURE MEDIA, CONDITIONED; EMBRYONIC STEM CELLS; ENDODERM; GENE EXPRESSION PROFILING; HUMANS; MICE; OCTAMER TRANSCRIPTION FACTOR-3; PHENOTYPE; PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS; TIME FACTORS;

EID: 84888870688     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.2684     Document Type: Article

References (49)

1. Levenstein, M.E. et al. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells 24, 568-574 (2006). (Pubitemid 44464760)
2. Bendall, S.C. et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448, 1015-1021 (2007). (Pubitemid 47345578)
3. Vallier, L., Alexander, M. & Pedersen, R.A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118, 4495-4509 (2005). (Pubitemid 41556347)
4. Avery, S., Zafarana, G., Gokhale, P.J. & Andrews, P.W. The role of SMAD4 in human embryonic stem cell self-renewal and stem cell fate. Stem Cells 28, 863-873 (2010).
5. Amit, M. et al. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat. Protoc. 6, 572-579 (2011).
6. Dahéron, L. et al. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22, 770-778 (2004). (Pubitemid 39166934)
7. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P. & Brivanlou, A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3specific inhibitor. Nat. Med. 10, 55-63 (2004). (Pubitemid 38524699)
8. Dravid, G. et al. Defining the role of Wnt/β-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells 23, 1489-1501 (2005). (Pubitemid 41740998)
9. International Stem Cell Initiative Consortium. et al. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell Dev. Biol. Anim. 46, 247-258 (2010).
10. Peerani, R. et al. Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J. 26, 4744-4755 (2007). (Pubitemid 350126801)
11. McBeath, R., Pirone, D.M., Nelson, C.M., Bhadriraju, K. & Chen, C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell 6, 483-495 (2004). (Pubitemid 38456178)
12. Maherali, N. & Hochedlinger, K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3, 595-605 (2008).
13. Chambers, S.M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275-280 (2009).
14. + pancreatic progenitors from human ES cell-derived endoderm cells. J. Mol. Cell Biol. 2, 50-60 (2010).
15. Hwang, Y.S. et al. Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc. Natl. Acad. Sci. USA 106, 16978-16983 (2009).
16. Sun, N. et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci. Transl. Med. 4, 130ra147 (2012).
17. Xu, C. et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19, 971-974 (2001). (Pubitemid 32947578)
18. Wang, L. et al. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 110, 4111-4119 (2007). (Pubitemid 350248470)
19. Xu, R.H. et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotechnol. 20, 1261-1264 (2002).
20. Pera, M.F. et al. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J. Cell Sci. 117, 1269-1280 (2004). (Pubitemid 38456107)
21. Vallier, L. et al. Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS ONE 4, e6082 (2009).
22. Smith, J.R. et al. Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev. Biol. 313, 107-117 (2008). (Pubitemid 350298306)
23. Vallier, L., Reynolds, D. & Pedersen, R.A. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev. Biol. 275, 403-421 (2004). (Pubitemid 40288095)
24. Paige, S.L. et al. Endogenous Wnt/β-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS ONE 5, e11134 (2010).
25. Vallier, L. et al. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 136, 1339-1349 (2009).
26. Lowell, S., Benchoua, A., Heavey, B. & Smith, A.G. Notch promotes neural lineage entry by pluripotent embryonic stem cells. PLoS Biol. 4, e121 (2006).
27. Boyer, L.A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005). (Pubitemid 41345211)
28. Mossman, A.K., Sourris, K., Ng, E., Stanley, E.G. & Elefanty, A.G. Mixl1 and Oct4 proteins are transiently co-expressed in differentiating mouse and human embryonic stem cells. Stem Cells Dev. 14, 656-663 (2005). (Pubitemid 43201899)
29. Chng, Z., Teo, A., Pedersen, R.A. & Vallier, L. SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells. Cell Stem Cell 6, 59-70 (2010).
30. James, D., Levine, A.J., Besser, D. & Hemmati-Brivanlou, A. TGFβ/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132, 1273-1282 (2005). (Pubitemid 40528787)
31. Wang, G. et al. Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem. Biophys. Res. Commun. 330, 934-942 (2005). (Pubitemid 40462176)
32. Gonzalez, R. et al. Screening the mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency. Proc. Natl. Acad. Sci. USA 107, 3552-3557 (2010).
33. Greber, B. et al. Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell 6, 215-226 (2010).
34. Vallier, L. et al. Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells 27, 2655-2666 (2009).
35. Yu, P.B. et al. BMP type I receptor inhibition reduces heterotopic ossification. Nat. Med. 14, 1363-1369 (2008).
36. Nostro, M.C. et al. Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 138, 861-871 (2011).
37. Osafune, K. et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 26, 313-315 (2008). (Pubitemid 351355125)
38. Yang, L. et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453, 524-528 (2008). (Pubitemid 351733312)
39. Kattman, S.J. et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8, 228-240 (2011).
40. Bock, C. et al. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439-452 (2011).
41. Snijder, B. et al. Population context determines cell-to-cell variability in endocytosis and virus infection. Nature 461, 520-523 (2009).
42. Hussein, S.M. et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58-62 (2011).
43. Amps, K. et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat. Biotechnol. 29, 1132-1144 (2011).
44. Hotta, A. et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat. Methods 6, 370-376 (2009).
45. Cheung, A.Y. et al. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum. Mol. Genet. 20, 2103-2115 (2011).
46. Peerani, R., Bauwens, C., Kumacheva, E. & Zandstra, P.W. Patterning mouse and human embryonic stem cells using micro-contact printing. Methods Mol. Biol. 482, 21-33 (2009).
47. Seki, T., Yuasa, S. & Fukuda, K. Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nat. Protoc. 7, 718-728 (2012).
48. Bauwens, C.L. et al. Geometric control of cardiomyogenic induction in human pluripotent stem cells. Tissue Eng. Part A 17, 1901-1909 (2011).
49. Rezania, A. et al. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 61, 2016-2029 (2012).